1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Chen, X; Li, Y; Liu, X; Malki, A; Qian, Y; Wang, X | 1 |
Atanasov, AG; Baumgartner, RR; Dirsch, VM; Ganzera, M; Heiss, EH; Steinmann, D; Stuppner, H | 1 |
2 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Glucose- and Triglyceride-lowering Dietary Penta-O-galloyl-α-D-Glucose Reduces Expression of PPARγ and C/EBPα, Induces p21-Mediated G1 Phase Cell Cycle Arrest, and Inhibits Adipogenesis in 3T3-L1 Preadipocytes.
Topics: 3T3-L1 Cells; Adipocytes, White; Adipogenesis; Animals; Diabetes Mellitus, Type 2; Dietary Supplements; Down-Regulation; Hydrolyzable Tannins; Hyperglycemia; Hyperinsulinism; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Obesity; Random Allocation | 2015 |
Bioactivity-guided isolation of 1,2,3,4,6-Penta-O-galloyl-D-glucopyranose from Paeonia lactiflora roots as a PTP1B inhibitor.
Topics: Austria; Carcinoma, Hepatocellular; Diabetes Mellitus, Type 2; Enzyme Assays; Humans; Hydrolyzable Tannins; Hypoglycemic Agents; Insulin; Paeonia; Plant Roots; Plants, Medicinal; Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2010 |